US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Gastrointestinal Market Research Reports & Industry Analysis

RSS Feeds

Gastrointestinal Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Digestive Remedies in Canada
12/4/2015 | published by: Euromonitor International
... was the growing older population, as older people typically experience more digestive health disorders, according to WebMD, due to a lack of physical activity, a lack of fluid intake and physiological changes. Based on Euromonitor ...  |  read more...
USD 990
Spain Ulcerative Colitis Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... research includes Spain ulcerative colitis market size estimates for 2014, market share forecast for six years to 2020, ulcerative colitis drugs market share, ulcerative colitis drugs sales estimates, ulcerative colitis drugs sales forecast, and ulcerative ...  |  read more...
USD 990
Germany Ulcerative Colitis Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... research includes Germany ulcerative colitis market size estimates for 2014, market share forecast for six years to 2020, ulcerative colitis drugs market share, ulcerative colitis drugs sales estimates, ulcerative colitis drugs sales forecast, and ulcerative ...  |  read more...
USD 990
Japan Ulcerative Colitis Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... research includes Japan ulcerative colitis market size estimates for 2014, market share forecast for six years to 2020, ulcerative colitis drugs market share, ulcerative colitis drugs sales estimates, ulcerative colitis drugs sales forecast, and ulcerative ...  |  read more...
USD 990
US Ulcerative Colitis Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... US. The research includes the US ulcerative colitis market size estimates for 2014, market share forecast for six years to 2020, ulcerative colitis drugs market share, ulcerative colitis drugs sales estimates, ulcerative colitis drugs sales ...  |  read more...
USD 990
Spain Gastro-Esophageal Reflux Disease Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... forecast in Spain. The research includes Spain gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux disease drugs market share, gastro-esophageal reflux disease drugs sales estimates, ...  |  read more...
USD 990
Italy Gastro-Esophageal Reflux Disease Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... forecast in Italy. The research includes Italy gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux disease drugs market share, gastro-esophageal reflux disease drugs sales estimates, ...  |  read more...
USD 990
US Gastro-Esophageal Reflux Disease Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... sales forecast in the US. The research includes the US gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux disease drugs market share, gastro-esophageal reflux disease ...  |  read more...
USD 990
Europe Gastro-Esophageal Reflux Disease Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain, and UK) gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux ...  |  read more...
USD 2,800
Inflammatory Bowel Diseases (IBD): World Drug Industry and Market 2015-2025
11/21/2014 | published by: Visiongain
... disease (IBD)? Those intestinal treatments retain high potential. Now you can explore sales forecasts and that industry’s research and development. See there how that large, profitable market expands. Visiongain’s new investigation predicts those revenues to ...  |  read more...
USD 2,375
Global Peptic Ulcer Drugs Market : 2014-2018
8/13/2014 | published by: TechNavio - Infiniti Research Ltd.
... plc., Daewoong Pharmaceutical Co. Ltd., Eisai Co. Ltd. and Takeda Pharmaceutical Co. Ltd. Other Prominent Vendors in the market are: Daiichi Sankyo, Dr. Reddy's Laboratories, Eumedica, Ferring Pharmaceuticals, Horizon Pharma , Johnson and Johnson, Merck ...  |  read more...
USD 2,500
Global Irritable Bowel Syndrome Market 2015-2019
11/19/2014 | published by: TechNavio - Infiniti Research Ltd.
... a chronic disease with recurrent immune response and inflammation of the GI tract, is sometimes confused with irritable bowel syndrome. The symptoms of irritable bowel syndrome generally appear in a patient aged around 30 years. ...  |  read more...
USD 2,500
Adult Diaper Market in Japan 2015-2019
12/24/2014 | published by: TechNavio - Infiniti Research Ltd.
... manner. They require to be replaced after usage. Baby diapers, underpants, and sanitary napkins are different forms of diapers. Adult diapers are usually used by people aged above 55 years. These people suffer from problems ...  |  read more...
USD 2,500
Xifaxan (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
Global Gastrointestinal Symptoms Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Gastrointestinal Symptoms Partnering 2010-2015 provides understanding and access to the gastrointestinal symptoms partnering deals and agreements entered into by ...  |  read more...
USD 1,495
The 2016 Report on Laxatives and Stool Softeners: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so ...  |  read more...
USD 995
Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015
4/30/2015 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Ileus (Intestinal Obstruction) . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ...  |  read more...
USD 2,500
Diarrhea Global Clinical Trials Review, H1, 2015
5/29/2015 | published by: GlobalData
... to the clinical trials on Diarrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015
6/30/2015 | published by: GlobalData
... Reflux Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Reflux Esophagitis (Gastroesophageal Reflux Disease) . Report includes an overview of trial numbers and their average enrollment in ...  |  read more...
USD 2,500
Inflammatory Bowel Disease - Pipeline Review, H1 2015
6/30/2015 | published by: Global Markets Direct
... information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Plecanatide (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
Tenapanor (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies ...  |  read more...
USD 4,995
PharmaPoint: Irritable Bowel Syndrome - Japan Drug Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies ...  |  read more...
USD 4,995
Gastric Ulcers - Pipeline Review, H1 2015
2/18/2015 | published by: Global Markets Direct
... therapeutic development for Gastric Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
6  7  8  9    11    13  14  15